Effects of Soy Protein/Soy Fiber on Measures of Satiety
NCT ID: NCT01358318
Last Updated: 2012-06-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
40 participants
INTERVENTIONAL
2011-02-28
2011-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study on the Effects of Soy Protein on Blood Lipids in Men and Women With Mild to Moderate Hypercholesterolemia
NCT00945737
Effect of Soy on HDL-C Function, Central Blood Pressure, and Arterial Stiffness
NCT02180841
Effect of Soymilk Replacement on Anthropometric and Blood Pressure Value
NCT01253876
The Effects of Soy Protein and Isoflavones on Glycemic Control, Insulin Sensitivity and Cardiovascular Risk Factors
NCT00856882
Comparison of the Efficacy of Plant Sterol-Enriched Soymilk Versus Plain Soymilk in Volunteers With High LDL-Cholesterol
NCT02459314
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
Satiety
Single consumption of snack bars to determine satiety and food intake at next meal.
Soy Protein
Satiety
Single consumption of snack bars to determine satiety and food intake at next meal.
Soy Fiber
Satiety
Single consumption of snack bars to determine satiety and food intake at next meal.
Soy Protein and Soy Fiber
Satiety
Single consumption of snack bars to determine satiety and food intake at next meal.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Satiety
Single consumption of snack bars to determine satiety and food intake at next meal.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age between 20-60y
* Unrestrained eater (score\<15)
* Regularly consume 3 meals per day
* Moderate exercise (eg running , aerobics classes, other sports activities) of no more than 7 hours per week
Exclusion Criteria
* presence of any significant disease (eg gastrointestinal diseases, diabetes, a CVD event less than 12 weeks from study entry, current hepatic disease etc)
* use of special dietary treatments or supplement within 4 weeks of study
* restrained eater (score\>15)
* weight change (±10% of body weight) within the previous 6 weeks
* alcohol intake \>2 drinks/day
* food allergies of any kind
* swallowing difficulties,
* exercising more than 7 hours per week
20 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Glycemic Index Laboratories, Inc
INDUSTRY
Solae, LLC
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Thomas Wolever, PhD
Role: PRINCIPAL_INVESTIGATOR
Glycemic Index Laboratories, Inc
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Glycemic Index Laboratories
Toronto, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GIL1103
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.